Inger Molvik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Inger Molvik has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Anne Brækhus
The Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway
1 shared publication- Anne Marie Mork Rokstad
Faculty of Health Sciences and Social Care, Molde University College, Molde, Norway; Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway
1 shared publication - Bjørn Heine Strand
Norwegian Institute of Public Health, Oslo, Norway
1 shared publication Eivind Aakhus
The Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway
1 shared publicationFiona E Matthews
Institute for Clinical and Applied Health Research, University of Hull, Hull, UK
1 shared publication- Geir Selbæk
Norwegian National Centre for Ageing and Health Vestfold Hospital Trust Tønsberg Norway
1 shared publication
Latest Publications
- Open Access
- 29 August 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1469-1480
Incidence of dementia among individuals 70 years and older in Norway: A HUNT study
Background: With increasing population longevity, Alzheimer's disease and dementia have become a health priority, and high-quality incidence estimates are needed. Objective: To provide reliable and precise incidence estimates of dementia applying a population-based sample of individuals aged 70+. Methods: A longitudinal cohort design was used, with baseline assessment in the Norwegian HUNT4 70+ study (2017–19) and at follow-up four years later (2021–23). Age-specific dementia incidence rates, standardized for the Norwegian population, were calculated as the number of new dementia cases per 1000 person-years assuming onset midway between study waves with inverse probability weights based on baseline factors associated with non-participation or death. Results: Among 5229 dementia-free individuals at baseline, 749 developed dementia over a 4.2-year period, resulting in a cumulative incidence proportion of 14.3%. At follow-up, 33.8% of new dementia cases showed no baseline cognitive impairment, while the rest had mild cognitive impairment (MCI). Of those with baseline MCI, 25.5% reverted to normal cognition, 48.2% remained MCI, and 26.2% developed dementia. The dementia incidence per 1000 person-years, was 43.9 (95% confidence interval (CI) 40.8, 47.1) (weighted for non-response and standardized to the dementia-free Norwegian population). Conclusions: Our study found higher dementia incidence rates in the 70+ population than hospital records indicate. Most individuals had preceding MCI, with similar numbers reverting to normal cognition as developing dementia. The projected incident dementia cases suggest a near doubling between 2023 and 2050, significantly impacting families and healthcare planning, including early detection and interventions.
- 29 August 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 107 (4) , 1469-1480
Open AccessIncidence of dementia among individuals 70 years and older in Norway: A HUNT study
Background: With increasing population longevity, Alzheimer's disease and dementia have become a health priority, and high-quality incidence estimates are needed. Objective: To provide reliable and precise incidence estimates of dementia applying a population-based sample of individuals aged 70+. Methods: A longitudinal cohort design was used, with baseline assessment in the Norwegian HUNT4 70+ study (2017–19) and at follow-up four years later (2021–23). Age-specific dementia incidence rates, standardized for the Norwegian population, were calculated as the number of new dementia cases per 1000 person-years assuming onset midway between study waves with inverse probability weights based on baseline factors associated with non-participation or death. Results: Among 5229 dementia-free individuals at baseline, 749 developed dementia over a 4.2-year period, resulting in a cumulative incidence proportion of 14.3%. At follow-up, 33.8% of new dementia cases showed no baseline cognitive impairment, while the rest had mild cognitive impairment (MCI). Of those with baseline MCI, 25.5% reverted to normal cognition, 48.2% remained MCI, and 26.2% developed dementia. The dementia incidence per 1000 person-years, was 43.9 (95% confidence interval (CI) 40.8, 47.1) (weighted for non-response and standardized to the dementia-free Norwegian population). Conclusions: Our study found higher dementia incidence rates in the 70+ population than hospital records indicate. Most individuals had preceding MCI, with similar numbers reverting to normal cognition as developing dementia. The projected incident dementia cases suggest a near doubling between 2023 and 2050, significantly impacting families and healthcare planning, including early detection and interventions.